CX-072 (pacmilimab), a Probody PD-L1 inhibitor, in combination with ipilimumab in patients with advanced solid tumors (PROCLAIM-CX-072): a first-in-human, dose-finding study
=============================================================================================================================================================================

* Rachel E Sanborn
* Omid Hamid
* Elisabeth GE de Vries
* Patrick A Ott
* Javier Garcia-Corbacho
* Valentina Boni
* Johanna Bendell
* Karen A Autio
* Daniel C Cho
* Ruth Plummer
* Mark Stroh
* Lawrence Lu
* Fiona Thistlethwaite